Skip to main content
Log in

c-Kit+ Cells Transplantation as a New Treatment for Autism, a Novel Hypothesis with Important Research and Clinical Implication

  • Letter to the Editor
  • Published:
Journal of Autism and Developmental Disorders Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  • Chez, M. G., Burton, Q., Dowling, T., Chang, M., Khanna, P., & Kramer, C. (2007). Memantine as adjunctive therapy in children diagnosed with autistic spectrum disorders: An observation of initial clinical response and maintenance tolerability. Journal of Child Neurology, 22(5), 574–579.

    Article  PubMed  Google Scholar 

  • Corti, S., Nizzardo, M., Nardini, M., Donadoni, C., Salani, S., Simone, C., et al. (2010). Systemic transplantation of c-kit+ cells exerts a therapeutic effect in a model of amyotrophic lateral sclerosis. Human Molecular Genetics, 19(19), 3782–3796.

    Article  PubMed  Google Scholar 

  • Danbolt, N. C. (2001). Glutamate uptake. Progress in Neurobiology, 65(1), 1–105.

    Article  PubMed  Google Scholar 

  • Ghanizadeh, A. (2010a). Transplantation of GABAergic cell line as a novel hypothesized treatment for autism. Epilepsy & Behavior, 19(4), 664.

    Article  Google Scholar 

  • Ghanizadeh, A. (2010b). Targeting neurotensin as a potential novel approach for the treatment of autism. Journal of Neuroinflammation, 7, 58.

    Article  PubMed  Google Scholar 

  • Ghanizadeh, A. (2011). Targeting of glycine site on NMDA receptor as a possible new strategy for autism treatment. Neurochemical Research. doi:10.1007/s11064-010-0381-2.

  • Harada, M., Taki, M. M., Nose, A., Kubo, H., Mori, K., Nishitani, H., et al. (2010). Non-invasive evaluation of the GABAergic/Glutamatergic system in autistic patients observed by MEGA-editing proton MR spectroscopy using a clinical 3 tesla instrument. Journal of Autism and Developmental Disorders. [Epub ahead of print].

  • Maragakis, N. J., & Rothstein, J. D. (2001). Glutamate transporters in neurologic disease. Archives of Neurology, 58(3), 365–370.

    Article  PubMed  Google Scholar 

  • Niederhofer, H. (2007a). Glutamate antagonists seem to be slightly effective in psychopharmacologic treatment of autism. Journal of Clinical Psychopharmacology, 27(3), 317–318.

    Article  PubMed  Google Scholar 

  • Niederhofer, H. (2007b). Treating autism pharmacologically: also tacrine might improve symptomatology in some cases. Journal of Child Neurology, 22(8), 1054; author reply 1054–1055.

    Google Scholar 

  • Robinson, M. B. (1998). The family of sodium-dependent glutamate transporters: A focus on the GLT-1/EAAT2 subtype. Neurochemistry International, 33(6), 479–491.

    Article  PubMed  Google Scholar 

  • Rothstein, J. D., Dykes-Hoberg, M., Pardo, C. A., Bristol, L. A., Jin, L., Kuncl, R. W., et al. (1996). Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate. Neuron, 16(3), 675–686.

    Article  PubMed  Google Scholar 

  • Shinohe, A., Hashimoto, K., Nakamura, K., Tsujii, M., Iwata, Y., Tsuchiya, K. J., et al. (2006). Increased serum levels of glutamate in adult patients with autism. Progress in Neuropsychopharmacology and Biological Psychiatry, 30(8), 1472–1477.

    Article  Google Scholar 

  • Silverman, J. L., Tolu, S. S., Barkan, C. L., & Crawley, J. N. (2010). Repetitive self-grooming behavior in the BTBR mouse model of autism is blocked by the mGluR5 antagonist MPEP. Neuropsychopharmacology, 35(4), 976–989.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ahmad Ghanizadeh.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ghanizadeh, A. c-Kit+ Cells Transplantation as a New Treatment for Autism, a Novel Hypothesis with Important Research and Clinical Implication. J Autism Dev Disord 41, 1591–1592 (2011). https://doi.org/10.1007/s10803-010-1174-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10803-010-1174-9

Keywords

Navigation